Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 1/2 1

Status

Completed 2Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 24INDUSTRY 8NETWORK 4NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Colorectal Neoplasms 26Rectal Neoplasms 19Colonic Neoplasms 18Leukemia 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Lymphoma 11Stomach Neoplasms 9Burkitt Lymphoma 7Pancreatic Neoplasms 5Leukemia, Biphenotypic, Acute 4Esophageal Neoplasms 4Adenocarcinoma Of Esophagus 4Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasm Metastasis 3Lymphoma, Large B-Cell, Diffuse 3Dendritic Cell Sarcoma, Interdigitating 3Lymphoma, Mantle-Cell 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Thrombocytopenia 1Sarcoma 1Rhabdoid Tumor 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Osteosarcoma 1Neutropenia 1Metastatic Small Intestinal Adenocarcinoma 1Metastatic Pancreatic Adenocarcinoma 1Medulloblastoma 1Leukemia, Myelomonocytic, Juvenile 1Hydatidiform Mole 1

Interventions

Fluorouracil 9Radiotherapy 8Cisplatin 7Paclitaxel 5Oxaliplatin 5Leucovorin 4Irinotecan 4Cetuximab 3Surgical Procedures, Operative 2Filgrastim 2Docetaxel 2uridine triacetate 1pegylated granulocyte colony-stimulating factor, human 1pegfilgrastim 1dehydroftorafur 1Sorafenib 1Radiation 1Polymerase Chain Reaction 1Platinum 1Granulocyte Colony-Stimulating Factor 1Gemcitabine 1Folfox protocol 1Drug Therapy 1Chemotherapy, Adjuvant 1Capecitabine 1Amplified Fragment Length Polymorphism Analysis 1AMG 337 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
NETWORK × Adenocarcinoma Of Esophagus × Leucovorin × Clear all
NCT04248452 2026-05-05

Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body

Eastern Cooperative Oncology Group

Phase 3 Active not recruiting
314 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus

NCT02344810 2023-05-25

C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal Cancer

Eastern Cooperative Oncology Group

Phase 1/2 Withdrawn
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Gastrointestinal Neoplasms, Stomach Neoplasms

NCT01498289 2019-11-07

S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer

SWOG Cancer Research Network

Phase 2 Completed
213 enrolled 17 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

NCT00004233 2011-07-25

S9915 Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or Stomach

SWOG Cancer Research Network

Phase 2 Completed
65 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡